MEDS (DataMEDS AI) Total Liabilities: $45.19 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DataMEDS AI Total Liabilities?

DataMEDS AI MEDS -3.35% Total Liabilities is $45.19 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

DataMEDS AI's Total Liabilities for the quarter that ended in Mar. 2026 was $45.19 Mil.

DataMEDS AI's quarterly Total Liabilities declined from Sep. 2025 ($46.00 Mil) to Dec. 2025 ($42.91 Mil) but then increased from Dec. 2025 ($42.91 Mil) to Mar. 2026 ($45.19 Mil).

DataMEDS AI's annual Total Liabilities increased from Dec. 2023 ($3.24 Mil) to Dec. 2024 ($50.60 Mil) but then declined from Dec. 2024 ($50.60 Mil) to Dec. 2025 ($42.91 Mil).


DataMEDS AI Total Liabilities Historical Data

* Premium members only.

The historical data trend for DataMEDS AI's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DataMEDS AI Total Liabilities Chart

DataMEDS AI Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
0.01 3.24 50.60 42.91

DataMEDS AI Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.58 53.32 46.00 42.91 45.19

DataMEDS AI Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

DataMEDS AI's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29.78+(13.127+-5.3290705182008E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=42.91

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=30.459--12.448
=42.91

DataMEDS AI's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=30.128--15.062
=45.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $45.19 Mil mean?
DataMEDS AI (MEDS) has a Total Liabilities of $45.19 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for DataMEDS AI and its competitors.
Is DataMEDS AI's Total Liabilities too high?
DataMEDS AI's current Total Liabilities is $45.19 Mil.
How does DataMEDS AI's Total Liabilities compare to HEWA and BLMH?
DataMEDS AI's Total Liabilities of $45.19 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for DataMEDS AI and its competitors. DataMEDS AI's current Total Liabilities is $45.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Total Liabilities of $45.19 Mil. The current Total Liabilities is $45.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Total Liabilities is $45.19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DataMEDS AI Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.